The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 29, 2019
Filed:
Mar. 25, 2016
Applicant:
Nantkwest, Inc., Culver City, CA (US);
Inventors:
Tien Lee, Culver City, CA (US);
Hans G. Klingemann, Culver City, CA (US);
Barry J. Simon, Culver City, CA (US);
Laurent Boissel, Culver City, CA (US);
Assignee:
NantKwest, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C07K 16/28 (2006.01); C12N 5/0783 (2010.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 39/39558 (2013.01); C07K 16/2887 (2013.01); C12N 5/0646 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/572 (2013.01); A61K 2300/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/732 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/48 (2013.01); C12N 2501/599 (2013.01); C12N 2501/727 (2013.01); C12N 2510/00 (2013.01);
Abstract
This invention is directed to treatment of a subject having or suspected of having a cancer comprising administering to the subject a monoclonal antibody and NK-92 expressing Fc receptor.